Zobrazeno 1 - 10
of 967
pro vyhledávání: '"Arthur J Moss"'
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68920 (2013)
The objective of this work was to investigate whether fibrinolysis plays a role in establishing recurrent coronary event risk in a previously identified group of postinfarction patients. This group of patients was defined as having concurrently high
Externí odkaz:
https://doaj.org/article/acb8fe7d36524690a33e3eed82796e02
Autor:
Valentina Kutyifa, Scott McNitt, Scott D. Solomon, Arthur J. Moss, Katherine Vermilye, Usama A. Daimee
Publikováno v:
European Journal of Heart Failure. 21:360-369
Despite our prior report suggesting heart failure (HF) risk reduction from cardiac resynchronization therapy with defibrillator (CRT-D) in mild HF patients with higher left ventricular ejection fraction (LVEF 30%), data on mortality benefit in this c
Autor:
Jesaia Benhorin, Arthur J. Moss, Matthew Bak, Wojciech Zareba, Elizabeth S. Kaufman, Batsheva Kerem, Jeffrey A. Towbin, Silvia Priori, Robert S. Kass, Bernard Attali, Arthur M. Brown, Eckhard Ficker
Publikováno v:
Annals of Noninvasive Electrocardiology, Vol 7, Iss 1, Pp 40-46 (2001)
Objectives: This study assessed the phenotypic variability of LQTS in carriers with the same and with different mutations in the LQT2 gene. Background: Mutations of ion‐channel genes are known to cause the long QT syndrome (LQTS), a disorder associ
Externí odkaz:
https://doaj.org/article/48befc71b3f34de49c996b5276d68d7b
Autor:
Annamaria Kosztin, Wojciech Zareba, Scott D. Solomon, Valentina Kutyifa, Arthur J. Moss, Yitschak Biton, Scott McNitt, Ilan Goldenberg, Helmut U. Klein, Vivien Klaudia Nagy, Jagmeet P. Singh, Béla Merkely, Attila Roka
Publikováno v:
JACC: Clinical Electrophysiology. 4:1410-1420
The authors aimed to evaluate the association of left ventricular (LV) lead location and long-term outcomes in MADIT-CRT (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).There is limited data on the associatio
Autor:
Helmut U. Klein, Usama A. Daimee, Wojciech Zareba, Valentina Kutyifa, Arthur J. Moss, Ilan Goldenberg, Katherine Vermilye, Scott McNitt
Publikováno v:
Heart Rhythm. 15:1379-1386
Use of the wearable cardioverter-defibrillator (WCD) in older patients has not been described previously.The purpose of this study was to assess WCD wear time, risk of arrhythmic events during WCD use, and implantable cardioverter-defibrillator (ICD)
Autor:
Wojciech Zareba, James P. Daubert, Christopher A. Beck, David T. Huang, Jeffrey D. Alexis, Mary W. Brown, Kathryn Pyykkonen, Scott McNitt, David Oakes, Changyong Feng, Mehmet K. Aktas, Felix Ayala-Parades, Adrian Baranchuk, Marc Dubuc, Mark Haigney, Alexander Mazur, Craig A. McPherson, L. Brent Mitchell, Andrea Natale, Jonathan P. Piccini, Merritt Raitt, Mayer Y. Rashtian, Claudio Schuger, Stephen Winters, Seth J. Worley, Ohad Ziv, Arthur J. Moss, W. Zareba, K. Pyykkonen, A. Buttaccio, E. Perkins, D. DeGrey, S. Robertson, A.J. Moss, M. Brown, R. Lansing, A. Oberer, B. Polonsky, V. Ross, A. Papernov, S. Schleede, C. Beck, D. Oakes, C. Feng, S. McNitt S, W.J. Hall, A. Moss, J. Daubert, D. Huang, S. Winters, C. Schuger, M. Haigney, J. Piccini, J. Alexis, L. Chen, A. Miller, J.F. Richeson, S. Rosero, V. Kutyifa, A. Shah, G. Lamas, F. Cohn, F. Harrell, I. Piña, J. Poole, M. Sullivan, D. Lathrop, N. Geller, R. Boineau, J. Trondell, L. Cooper, E. Itturiaga, C. Gottlieb, S. Greer, C. Perzanowski, C. McPherson, C. Hedgepeth, C. Assal, T. Salam, I. Woollett, G. Tomassoni, F. Ayala-Paredes, A. Russo, S. Punnam, R. Sangrigoli, S. Sloan, S. Kutalek, A. Sun, D. Lustgarten, G. Monir, D. Haithcock, R. Sorrentino, D. Cannom, J. Kluger, S. Varanasi, M. Rashtian, F. Philippon, R. Berger, M. Mazzella, T. Lessmeier, J. Silver, S. Worley, M. Bernabei, D. Esberg, M. Dixon, P. LeLorier, Y. Greenberg, V. Essebag, G. Venkataraman, T. Shinn, M. Dubuc, G. Turitto, C. Henrikson, M. Mirro, M. Raitt, A. Baranchuk, G. O'Neill, E. Lockwood, M. Vloka, J. Hurwitz, R.H. Mead, P. Somasundarum, E. Aziz, E. Rashba, A. Budzikowski, M. Cox, A. Natale, E. Chung, O. Ziv, F. McGrew, K. Tamirisa, A. Greenspon, M. Estes, S. Taylor, R. Janardhanan, L.B. Mitchell, M. Burke, M. Attari, B. Mikaelian, S. Hsu, J. Conti, A. Mazur, S. Shorofsky, L. Rosenthal, S. Sakaguchi, D. Wolfe, G. Flaker, S. Saba, M. Aktas, P. Mason, A. Shalaby, D. Musat, R. Abraham, K. Ellenbogen, C. Fellows, N. Kavesh, G. Thomas, D. Hemsworth, B. Williamson
Publikováno v:
Journal of the American College of Cardiology. 72:636-645
Background Ventricular tachycardia (VT) and ventricular fibrillation (VF) remain a challenging problem in patients with implantable cardioverter-defibrillators (ICDs). Objectives This study aimed to determine whether ranolazine administration decreas
Autor:
Valentina Kutyifa, Helmut U. Klein, Ilan Goldenberg, Scott McNitt, Arthur J. Moss, Wojciech Zareba
Publikováno v:
Pacing and Clinical Electrophysiology. 41:1307-1313
Background The WEARIT-II Registry demonstrated efficacy and safety of the wearable cardioverter defibrillator (WCD) for at-risk cardiac patients. However, 1-year outcomes in this population have not been reported. Methods The WEARIT-II Registry enrol
Autor:
Yitschak Biton, Scott McNitt, Bronislava Polonsky, Arthur J. Moss, Ilan Goldenberg, Valentina Kutyifa, Wojciech Zareba, Jayson R. Baman, Spencer Rosero
Publikováno v:
EP Europace. 21:339-346
Aims Prospective data regarding the role of implantable cardioverter-defibrillator (ICD) for the primary prevention of sudden cardiac death in patients with long QT syndrome (LQTS) is scarce. Herein, we explore the prospective Rochester LQTS ICD regi
Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death
Autor:
Usama A. Daimee, Arthur J. Moss, Katherine Vermilye, Scott McNitt, Helmut U. Klein, Valentina Kutyifa
Publikováno v:
EP Europace. 20:f225-f232
Aims Data on outcomes in patients using the wearable cardioverter-defibrillator (WCD) > 90 days are limited. We aimed to analyse the clinical course of patients with WCD use ≤90 days vs. WCD use >90 days. Methods and results We assessed arrhythmia
Autor:
Syed Yaseen Naqvi, Scott McNitt, Ilan Goldenberg, Arthur J. Moss, Valentina Kutyifa, Helmut U. Klein, Mary W. Brown
Publikováno v:
The American Journal of Cardiology. 121:1567-1574
We have previously shown a reduction in HF events with cardiac resynchronization therapy with defibrillator (CRT-D) in patients with mild heart failure (HF) and diabetes mellitus (DM). It remains unknown whether HF remission in DM patients with CRT-D